Eva Agnes Odongpiny Laker (Eva Laker Agnes Odongpiny, Eva Laker)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Cervical Cancer Screening

Polycystic Ovary Syndrome

Hiv Infected Patients

Top Venues

JMIR mHealth and uHealth

BMC infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Eva Agnes Odongpiny Laker, Fiona V Cresswell, Arnold Arinaitwe, Vivian Nakate, Joshua Kyenkya, Mohammed Lamorde, Catriona Waitt, David Meya, Agnes Kiragga
High willingness to use injectable antiretroviral therapy among women who have been lost to follow-up from HIV programmes: A nested cross-sectional study. HIV medicine 23 (4) (2022)
Dathan Mirembe Byonanebye, Maria Sarah Nabaggala, Agnes Bwanika Naggirinya, Mohammed Lamorde, Elizabeth Oseku, Rachel Lisa King, Noela Owarwo, Eva Agnes Odongpiny Laker, Richard Orama, Castelnuovo Barbara, Agnes N Kiragga, Rosalind Parkes-Ratanshi
An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial. JMIR mHealth and uHealth 9 (2) (2021)
Eva Agnes Odongpiny Laker, Arnold Arinaitwe, Noela Owarwo, Annet Onzia, Benson Nasasira, Abdullah Wailagala, Ivan Kalule, Godwin Anguzu, Agnes Kiragga, Kay Seden, Isaac Lwanga, Barbara Castelnuovo, Rachel Musomba, Mohammed Lamorde
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by Women. Drug safety 43 (11) (2021)
Eva Agnes Odongpiny Laker, Maria Sarah Nabaggala, Arvind Kaimal, Damalie Nalwanga, Barbara Castelnuovo, Abdu Musubire, Agnes Kiragga, Mohammed Lamorde, Rosalind Parkes- Ratanshi
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir. BMC infectious diseases 19 (1) (2019)